Cochlear (ASX:COH) shares rise on reports of strong global growth

[videojs_hls url=’//du7x25at22z7c.cloudfront.net/317937/index_HLSv3.m3u8′ poster=’http://www.finnewsnetwork.com.au/newssystem/2021/Headlines03_360_210219.jpg’]

Cochlear (ASX:COH) report strong growth in the US, Japan, Korea and China, improving momentum in Western Europe and a slower recovery across most emerging markets.

Statutory net profit for the half is $236.2 million, benefiting from a number of one-off gains.

Sales revenue declined 4 per cent to $742.8 million, with the first quarter down 8 per cent and the second quarter up 7 per cent.

Cochlear implant units declined 8 per cent.

The dividend has been re-introduced as a result of improved trading conditions and cash flow generation with an interim dividend of $1.15 per share.

Shares in Cochlear (ASX:COH) are trading 7.82 per cent higher at $220.50.
 
Copyright 2021 – Finance News Network

Source: Finance News Network